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INTRODUCTION
Fibroblasts and many other cell types in culture develop spe-
cialized adhesions to the underlying substratum, known as
focal adhesions (focal contacts, adhesion plaques) (for reviews
see: Burridge et al., 1988; Geiger 1989; Tsukita et al., 1990).
These are the regions of tightest adhesion to the substratum
and, at their cytoplasmic face, focal adhesions anchor bundles
of actin filaments (stress fibers). Since focal adhesions only
develop on surfaces coated with extracellular matrix (ECM)
components, they serve as a convenient model for studying the
adhesive interactions of cells with ECM. Focal adhesions are
not only sites of structural linkage between the ECM and the
cytoskeleton, but an abundance of recent evidence indicates
that these are also sites of transmembrane signaling (Burridge
et al., 1992a; Hynes, 1992; Juliano and Haskill, 1993; Bockholt
and Burridge, 1994).
Although much has been learned about the components of
focal adhesions, many questions about the assembly and dis-
assembly of these structures remain unanswered. One system
used to study the assembly of focal adhesions has been to
observe their formation in cells plated directly onto a substrate
coated with an ECM protein, such as fibronectin. Using this
system evidence has been found for a role of tyrosine phos-
phorylation in the assembly of focal adhesions. Several focal
adhesion proteins become tyrosine phosphorylated as cells
adhere to and spread on fibronectin (Guan et al., 1991;
Burridge et al., 1992b; Bockholt and Burridge, 1993), and
tyrosine kinase inhibitors prevent the formation of focal
adhesions (Burridge et al. 1992b; Romer et al., 1992, 1994).
One of the major tyrosine phosphorylated, focal adhesion
proteins is itself a tyrosine kinase, the focal adhesion kinase
(FAK) (Hanks et al., 1992; Schaller et al., 1992; Whitney et
al., 1993). FAK becomes tyrosine phosphorylated and
activated in response to either integrin-mediated adhesion
(Guan and Shalloway, 1992; Burridge et al., 1992b; Hanks et
al., 1992; Kornberg et al., 1992; Lipfert et al., 1992; Romer et
al., 1992, 1994), or integrin clustering by antibodies (Kornberg
et al., 1991). 
A disadvantage of examining the formation of focal
adhesions as cells spread on an ECM-coated surface is that
focal adhesions form asynchronously and spreading is usually
a slow and complex process. A different model system for
studying focal adhesion assembly has been developed by
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Tyrosine phosphorylation is known to regulate the
formation of focal adhesions in cells adhering to extracel-
lular matrix (ECM). We have investigated the possible
involvement of tyrosine phosphorylation and the focal
adhesion kinase (FAK) in the cytoskeletal changes induced
by serum or lysophosphatidic acid (LPA) in quiescent
Swiss 3T3 fibroblasts. As shown previously by others,
quiescent cells stimulated with serum or LPA reveal a
rapid reappearance of focal adhesions and stress fibers.
Here we show that this is accompanied by an increase in
phosphotyrosine in focal adhesions and specifically an
increase in the tyrosine phosphorylation of FAK. The LPA-
stimulated reappearance of focal adhesions and stress
fibers is blocked by inhibitors of phospholipase C but not
by pertussis toxin (PTX), indicating that this LPA signaling
pathway is mediated by phospholipase C activation and
does not involve PTX-sensitive G proteins. In the absence
of serum or LPA, these cytoskeletal effects and the tyrosine
phosphorylation of FAK can be mimicked by sodium
orthovanadate in conjunction with hydrogen peroxide,
agents that inhibit protein tyrosine phosphatases and
thereby elevate levels of phosphotyrosine. Two tyrosine
kinase inhibitors, erbstatin and genistein block both the
serum-induced tyrosine phosphorylation of FAK and the
assembly of focal adhesions and stress fibers. Two other
tyrosine kinase inhibitors, tyrphostins 47 and 25, previ-
ously shown to inhibit FAK, failed to prevent FAK phos-
phorylation or the reassembly of focal adhesions and stress
fibers in response to serum. However, these inhibitors did
prevent FAK phosphorylation and cytoskeletal assembly in
response to lysophosphatidic acid (LPA), one component of
serum previously shown to stimulate assembly of focal
adhesions and stress fibers. Our findings suggest that the
response to serum is complex and that although FAK phos-
phorylation is important, other tyrosine kinases may also
be involved.
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Ridley and Hall (1992). These investigators found that
quiescent, serum-starved Swiss 3T3 fibroblasts have very few
stress fibers or focal adhesions, but serum stimulation rapidly
restores these structures. Ridley and Hall identified lysophos-
phatidic acid (LPA) as a component of serum responsible for
this effect. Furthermore, they demonstrated that the low
molecular mass GTP-binding protein RhoA is involved in
mediating the formation of focal adhesions and stress fibers
under these conditions. Inhibiting RhoA activity with C3 exo-
transferase blocks the serum-stimulated reappearance of focal
adhesions (Ridley and Hall, 1992; Chardin et al., 1989),
whereas microinjection of activated RhoA induces focal
adhesion formation in serum-starved, quiescent cells (Ridley
and Hall, 1992; Paterson et al., 1990).
In this paper, we have asked whether the rapid formation of
focal adhesions in quiescent cells responding to serum or LPA
also involves tyrosine phosphorylation. We have found that the
assembly of focal adhesions and stress fibers is accompanied
by an elevation in the tyrosine phosphorylation of FAK. In
addition, we have found that this assembly is blocked by
inhibiting tyrosine phosphorylation and can be mimicked by
inhibiting tyrosine phosphatases.
MATERIALS AND METHODS
Cell culture, protein tyrosine kinase inhibitors, protein
tyrosine phosphatase inhibitors
Swiss 3T3 fibroblasts (American Type Culture Collection), were
grown in Dulbecco’s modified Eagle’s medium (DMEM) (Life Tech-
nologies, Inc.), with 100 units/ml penicillin, 100 
 
µg/ml streptomycin
and 250 ng/ml amphotericin B as fungizone, supplemented with 10%
bovine calf serum, BCS (JRH Biosciences, Lenexa, KS). To obtain
quiescent cells we modified a previously described protocol (Ridley
and Hall, 1992). Briefly, in each experiment cells were seeded at
identical density in 100 mm tissue culture dishes and maintained in the
culture medium with serum, without feeding. The cells were used 7-
10 days after they reached confluence. The cells were then extensively
washed and starved in serum-free culture medium for 20-36 hours.
Quiescent, serum-starved cells were stimulated with culture medium
containing 0.5% fetal bovine serum (FBS) (JRH Biosciences) for 30
minutes. In some experiments 0.2-2.0 µg/ml lysophosphatidic acid
(LPA; 1-oleoyl-2-hydroxy-sn-glycero-3-phosphate, monosodium salt
in water) (Avanti, Alabaster, AL) was used to stimulate cells instead
of serum.
For some experiments, cells were treated with indicated concen-
trations of tyrphostin 47 (Biomol Research Labs, Inc.) or tyrphostin
25 (Gibco BRL, Gaithersburg, MD) in dimethyl sulfoxide (DMSO)
during serum starvation and following stimulation. For some experi-
ments erbstatin analog (EA; methyl 2,5-dihydroxycinnamate, 5-50
µg/ml, Biomol) or genistein (100-250 µg/ml, Biomol) were added to
the culture medium for the last 1 or 3 hours of starvation, and during
stimulation with 0.5% FBS.
In some experiments either 1 mM sodium orthovanadate and 3 mM
hydrogen peroxide or 50 µM phenylarsine oxide were added after
starvation to the serum-free culture media for 10-30 minutes, instead
of 0.5% FBS. 
Phospholipase C inhibitors and pertussis toxin
To study the role of phospholipase C (PLC) in the response to LPA,
the aminosteroid U-73122 (1-[6-[[17 betha-3-Methoxyestra-
1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione), or its
inactive analog, U-73343 (1-[6-[[17 betha-3-Methoxyestra-1,3,5(10)-
trien-17-yl]amino]hexyl]-1H-pyrrolidine-2,5-dione), (both from
Biomol), at 10 µM, was added to the culture media during stimula-
tion with LPA. In some experiments pertussis toxin (PTX), an
inhibitor of some heterotrimeric G proteins, was present in the culture
media during the last 2 hours of starvation and during stimulation with
LPA. The PTX concentration range was 100-500 ng/ml.
Immunoprecipitation and immunoblotting
Cells were lysed on ice with cold lysis buffer consisting of Tris-
buffered saline (TBS; 150 mM NaCl, 50 mM Tris-Cl, pH 7.6) with
0.1% sodium azide, 0.1% Triton X-100, 0.1% sodium deoxycholate,
2 mM EDTA, 2 mM EGTA, 1 mM sodium orthovanadate and 25
µg/ml leupeptin. The lysates were clarified by a 15 minute centrifu-
gation in a microfuge. Supernatants were incubated with 2A7, anti-
FAK monoclonal IgG (Upstate Biotechnology, Inc.) or with anti-
phosphotyrosine, py20 (ICN Biochemicals, Costa Mesa, CA) for at
least 4 hours. Antigen-antibody complexes were then precipitated by
rotating for 1 hour at 4°C with rabbit anti-mouse-conjugated Protein
A-Sepharose (Chemicon International, Temecula, CA). Beads were
pelleted by centrifugation and washed 3 times in lysis buffer. Proteins
bound to the Sepharose were then released by boiling in sample buffer
and electrophoresed on 7.5% polyacrylamide gels as described by
Laemmli (1970) with a bisacrylamide concentration of 0.19%.
Proteins were transferred electrophoretically to nitrocellulose and
blocked with 2% cold water fish gelatin (Sigma) in TBSTB (TBS with
0.1% bovine serum albumin and 0.05% Tween-20) for 20-30 minutes.
The nitrocellulose was then probed for 45 minutes with anti-phos-
photyrosine IgG conjugated to horseradish peroxidase, py20-HRP
(ICN Biochemicals), at 1:10,000 dilution. Following this incubation,
the blots were extensively washed with several changes of TBSTB
and TBS. Enhanced chemiluminesence (Amersham, UK) was used to
develop the blots. Immunoblots were stripped in 62.5 mM Tris-HCl,
pH 6.75, 2% sodium dodecyl sulfate and 100 mM β-mercaptoethanol
at 55°C for 45 minutes. Stripped blots were washed in TBS for 16
hours and reprobed with 2A7 antibody at 1:1,000 in TBSTB. After
washing in TBSTB the blots were incubated with HRP-conjugated
goat anti-mouse IgG (Jackson Immunoresearch, West Grove, PA) at
1:10,000 dilution.
[35S]methionine metabolic labeling and phosphotyrosine
quantitation
For quantitation of tyrosine phosphorylation, cells were washed
briefly with glutamine-, cysteine- and methionine-free culture
medium (ICN Biochemicals) and incubated with culture medium
(10% serum, 10% DMEM and 80% DMEM without cysteine or
methionine) containing 0.5 mCi [35S]methionine and cysteine
overnight. Cells were then washed in serum-free media, starved and
stimulated for 2-30 minutes as described above. Lysates were
prepared (see above) and precleared with Protein A coupled to
Sepharose for 1-3 hours. The lysates were divided in half and
immunoprecipitated with either anti-FAK or anti-phosphotyrosine
antibodies. The immunoprecipitates were analyzed on 7.5% SDS gels,
which were then stained with Coomasie Blue to reveal the molecular
mass markers, destained and incubated for 30 minutes in Amplify
(Amersham, Arlington Heights, Illinois). After drying, gels were
exposed to X-ray film overnight. Bands corresponding to FAK were
excised from the gel and 35S-incorporation was measured in the scin-
tillation counter. To normalize for FAK content, the number of counts
in the phosphotyrosine immunoprecipitate was divided by the number
of counts obtained from the corresponding FAK immunoprecipitate.
The results were expressed as percent increase above the unstimu-
lated, quiescent cells.
Immunofluorescence
For visualization of stress fibers and focal adhesion components, cells
plated on coverslips under conditions described above were fixed in
3.7% formaldehyde in PBS for 7 minutes, washed in TBS with 0.1%
azide and permeabilized with 0.5% Triton X-100. Actin was stained
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with 400 mU/ml TRITC-phalloidin (Molecular Probes, Inc., Eugene,
OR). Focal adhesions were visualized using either anti-phosphotyro-
sine, py20 (ICN Biochemicals) or monoclonal anti-vinculin, kindly
provided by Dr Alexey Belkin (Glukhova et al., 1990); followed by
TRITC- or FITC-labeled goat anti-mouse IgG, respectively
(Chemicon). Immunolabeling was performed at 37°C for 45 minutes
for each antibody.
RESULTS
Serum-induced reorganization of the cytoskeleton is
accompanied by changes in FAK phosphorylation
Ridley and coworkers have reported previously the morpho-
logical changes in cytoskeletal organization that occur when
quiescent Swiss 3T3 fibroblasts are stimulated with low con-
centrations of serum (Ridley and Hall, 1992; Ridley et al.,
1992). We have examined the changes in phosphotyrosine in
quiescent cells responding to serum stimulation. Phosphotyro-
sine staining (Fig. 1C,F,I) was compared with vinculin (Fig.
1A,D,G) and actin (Fig. 1B,E,H) staining. The changes in
phosphotyrosine staining that occurred in 3T3 fibroblasts upon
24-hour serum-depletion, and following stimulation with 0.5%
FBS for 30 minutes were similar to the changes in vinculin dis-
tribution. Phosphotyrosine was very prominent in the focal
adhesions of the control, confluent fibroblasts (Fig. 1C). Upon
serum-starvation the amount of phosphotyrosine staining in
focal adhesions was greatly reduced (Fig. 1F), and the number
of focal adhesions decreased. These changes in focal adhesion
staining were accompanied by a reduction in number and size
of stress fibers (Fig. 1E). In addition, remaining bundles of
actin filaments had an unusual morphology, which was mostly
peripheral. Stimulation of the cells with 0.5% FBS induced
rapid changes in the appearance of the actin cytoskeleton.
Within 30 minutes phosphotyrosine staining in focal adhesions
greatly increased (Fig. 1I). There was an increase in the
number of focal adhesions, that stained positively for both
vinculin (Fig. 1G) and phosphotyrosine (Fig. 1H). The focal
adhesions were large, elongated and could be found both at the
cell periphery and more centrally (Fig. 1G,I). These focal
adhesions were accompanied by new stress fibers (Fig. 1H),
which often appeared to cover much of the ventral surface of
the cell. We also examined whether there was a reorganization
of ECM components, such as fibronectin, in parallel with the
cytoskeletal rearrangements. Staining for fibronectin revealed
no detectable difference between the starved and the serum- or
LPA-stimulated cells (data not shown).
Since FAK tyrosine phosphorylation has been observed
during formation of new focal adhesions in cells adhering to
ECM (Burridge et al., 1992b; Guan and Shalloway, 1992;
Fig. 1. Vinculin, actin and phosphotyrosine immunolocalization in quiescent 3T3 fibroblasts stimulated with serum. 3T3 cells were grown 7-10
days past confluence in 10% BCS, without feeding (A,B,C), then cells were serum-starved for 24 hours (D,E,F) and stimulated with 0.5% FBS
for 30 minutes (G,H,I). Cells were fixed, permeabilized and stained with anti-vinculin antibody (A,D,G), fluorescent phalloidin (for actin)
(B,E,H) and anti-phosphotyrosine antibody (C,F,I). Bar, 20 µm.
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Hanks et al., 1992; Kornberg et al., 1992; Romer et al., 1992,
1994), we examined FAK phosphorylation in serum-stimu-
lated, quiescent Swiss 3T3 fibroblasts. Immunoprecipitated
FAK was heavily phosphorylated on tyrosine in confluent
Swiss 3T3 fibroblasts grown in 10% BCS (Fig. 2, lane 1).
Serum-starvation caused a decrease in FAK tyrosine phospho-
rylation (Fig. 2, lane 2). FAK phosphorylation increased upon
stimulation with 0.5% FBS (Fig. 2, lane 3).
We have found here that the changes in the phosphotyrosine
staining upon starvation and following serum treatment are
similar to the changes in vinculin staining under the same con-
ditions (as shown here and reported previously (Ridley and
Hall, 1992)). Increased phosphorylation of FAK parallels and
may be associated with the elevated phosphotyrosine staining
in focal adhesions of stimulated cells.
Inhibition of cytosolic phosphatases mimics effects
of serum on Swiss 3T3 fibroblasts
Sodium orthovanadate in conjunction with hydrogen peroxide
(pervanadate) acts as a potent inhibitor of a variety of cellular
phosphatases in vivo (Heffetz et al., 1990; Bushkin et al., 1991;
Volberg et al., 1991). Volberg and colleagues have shown that
pervanadate treatment of MDCK cells causes rapid formation
of focal adhesions (Volberg et al., 1992). In addition, increased
tyrosine phosphatase activity has been associated with cell
detachment from the substratum and focal adhesion disassem-
bly (Maher, 1993). To examine the effects of tyrosine phos-
phatase inhibition on the organization of the cytoskeleton in
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Swiss 3T3 fibroblasts that
were grown 7-10 days past
confluence in 10% BCS
(lanes 1 and 4), and starved
in the absence of serum for
24 hours (lanes 2 and 5) and
then stimulated with 0.5%
FBS for 30 minutes (lanes 3
and 6). The blot was first
probed with anti-
phosphotyrosine antibody
(left panel, lanes 1-3), then
stripped and reprobed with
anti-FAK antibody (right
panel, lanes 4-6). The
molecular masses of marker proteins are indicated in kilodaltons and
Ig indicates immunoglobulins.
Fig. 3. Pervanadate, but not phenylarsine oxide, mimics the effect of serum on the actin cytoskeleton in quiescent 3T3 fibroblasts. Quiescent
fibroblasts, starved for 24 hours (A,B,C), were incubated with 1 mM sodium orthovanadate and 3 mM hydrogen peroxide (D,E,F) or 50 µM
phenylarsine oxide (G,H,I) in serum-free media for 20 minutes. Cells were fixed, permeabilized and stained for vinculin (A,D,G), actin (B,E,H)
or phosphotyrosine (C,F,I), as described in Fig. 1. Bar, 20 µm.
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quiescent Swiss 3T3 fibroblasts, we tested 1 mM sodium ortho-
vanadate with 3 mM hydrogen peroxide (Fig. 3). Very
abundant and prominent stress fibers formed across the ventral
cell surface (Fig. 3E) within 10 minutes of treatment. These
new stress fibers were anchored in large, well developed focal
adhesions (Fig. 3D). Phosphotyrosine staining in pervanadate
treated cells was most intense at the peripheral focal adhesions,
but was present at a high level throughout the cytoplasm (Fig.
3F).
The elevation in phosphotyrosine staining induced by per-
vanadate treatment of quiescent fibroblasts (Fig. 3) correlated
with an elevation in FAK phosphorylation (Fig. 4, lane 3) to a
level similar to that of serum-stimulated cells (Fig. 4A, lane 2).
A marked shift in the mobility of FAK was observed in cells
treated with pervanadate (Fig. 4A, lanes 3 and 6). Since FAK
with equivalent levels of tyrosine phosphorylation (Fig. 4A,
lane 2) did not reveal this shift in mobility, we suspect that it
was most likely due to additional phosphorylation on serine
and/or threonine residues. Similar shifts in mobility have been
noted for other proteins upon phosphorylation, such as MAP
kinase (Boulton and Cobb, 1991). Phenylarsine oxide, a
tyrosine phosphatase inhibitor specific for the membrane-asso-
ciated phosphatases (Garcia-Morales et al., 1990; Liao et al.,
1991), neither stimulated the formation of focal adhesions and
stress fibers (Fig. 3G,H,I), nor induced FAK tyrosine phos-
phorylation (Fig. 4B, lane 3). 
These data support the idea that the observed changes in the
cytoskeleton of Swiss 3T3 fibroblasts are related to levels of
tyrosine phosphorylation. Increasing tyrosine phosphorylation
with some tyrosine phosphatase inhibitors led to the formation
of stress fibers and focal adhesions.
Involvement of kinases in the formation of stress
fibers and focal adhesions
The increased tyrosine phosphorylation of FAK observed upon
serum-stimulation, could result from tyrosine kinase activa-
tion, or tyrosine phosphatase inhibition. To investigate the pos-
sibility of a tyrosine kinase involvement, we used two different
tyrosine kinase inhibitors during serum-stimulation of
quiescent fibroblasts. Erbstatin analog (EA) (Umezawa et al.,
1986; Imoto et al., 1987; Isshiki et al., 1987) inhibited serum
induction of focal adhesions (Fig. 5G,I), and stress fibers (Fig.
5H). This response to EA was dose-dependent (data not
shown). Furthermore, EA decreased FAK phosphorylation
below the level of serum-starved cells (Fig. 6, lanes 3,4).
Genistein (4′,5,7-trihydroxyisoflavone) competitively
inhibits ATP binding to the kinase domain of several tyrosine
kinases (Akiyama et al., 1987; Linassier et al., 1989). The
presence of genistein at 100 µg/ml and above (for higher con-
centrations the data are not shown) completely inhibited the
formation of focal adhesions (Fig. 5J,L), and prevented the
increase in number of stress fibers (Fig. 5K) in fibroblasts stim-
ulated with 0.5% FBS (compare to 0.5% FBS alone in Fig.
5D,E,F). FAK precipitates from fibroblasts stimulated with
0.5% FBS in the presence of genistein showed lower levels of
tyrosine phosphorylation (Fig. 6, lanes 5,6) than seen in pre-
cipitates from serum-starved cells (Fig. 6, lane 1). 
The ability of the kinase inhibitors, EA and genistein, to
prevent serum-induced changes in the cytoskeleton and corre-
sponding changes in FAK phosphorylation, indicates that one
or more kinases are involved in the observed effects of serum.
Some tyrosine kinase inhibitors block cytoskeletal
response to LPA, but not serum
Lysophosphatidic acid (LPA) is a lipid in serum that stimulates
the reappearance of the stress fibers and focal adhesions in
quiescent Swiss 3T3 fibroblasts (Ridley and Hall, 1992). Fig.
7 shows the effect of LPA on quiescent Swiss 3T3 cells. LPA
at 200 ng/ml induced vinculin (Fig. 7G) and phosphotyrosine
(Fig. 7I) staining in focal adhesions to the level seen in 0.5%
FBS-stimulated fibroblasts (Fig. 7D,F). Like serum (Fig. 7E),
LPA induced the formation of many new stress fibers (Fig.
7H). LPA treatment caused increased tyrosine phosphorylation
of FAK (Fig. 9, lane 3) to a level similar to that with serum
(Fig. 9, lane 2). A similar increase in tyrosine phosphorylation
of FAK in response to LPA has been reported by others
(Kumagai et al., 1993; Seufferlein and Rozengurt, 1994). The
increase in tyrosine phosphorylation of FAK upon 5-minute
treatment with 0.5% serum or 2 µg/ml LPA was determined
by 35S-metabolic labeling and immunoprecipitation of FAK
with anti-phosphotyrosine and anti-FAK antibodies. Under
these conditions there was an increase in FAK tyrosine phos-
phorylation of approximately 70%.
These effects of LPA can be inhibited by a subset of tyr-
phostins. Tyrphostin 47 (AG 213) and tyrphostin 25 (3,4,5-tri-
Fig. 4. Pervanadate but not phenylarsine oxide stimulates tyrosine
phosphorylation of FAK. 3T3 cells were grown in 10% BCS for 7-10
days past confluence, starved for 24 hours in serum-free media (A
and B, lane 1) and stimulated with serum (A and B, lane 2) or 1 mM
sodium orthovanadate and 3 mM hydrogen peroxide (A, lane 3) or
50 µM phenylarsine oxide (B, lane 3) in serum-free media. Cell
lysates were immunoprecipitated with anti-FAK antibody and probed
with anti-phosphotyrosine. The blot was stripped and reprobed with
anti-FAK antibody to confirm that equal amounts of the
immunoprecipitated protein were present in each lane (A, lanes 4-6
correspond to lanes 1-3, and data not shown).
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hydroxy cis-cinnamonitrile) have been used to inhibit FAK
phosphorylation in response to adhesion (Romer et al., 1994)
and bombesin stimulation (Seckl and Rozengurt, 1993). The
addition of 120 µM tyrphostin 47 during serum-starvation and
LPA stimulation abolished the effect of LPA on the cytoskele-
ton by inhibiting the reappearance of focal adhesions (Fig. 8E)
and stress fibers (Fig. 8F). Similar results were obtained with
tyrphostin 25 (data not shown). Decreased phosphorylation of
FAK accompanied the inhibition of cytoskeletal reorganiza-
tion. Treatment of starved 3T3 fibroblasts with LPA and tyr-
phostin 47 (Fig. 9, lane 7), or tyrphostin 25 (Fig. 9, lane 8)
resulted in the complete inhibition of FAK phosphorylation,
compared to LPA alone (Fig. 9, lane 4). However, when tyr-
phostins 47 and 25 were used with 0.5% FBS only small inhi-
bition of FAK phosphorylation was observed (Fig. 9, lane 6,
and data not shown ). Additionally, neither tyrphostin seemed
to have a major effect on the cytoskeletal response to serum
(Fig. 8C,D and data not shown). 
LPA signaling and the reappearance of the actin
cytoskeleton
LPA signaling involves two separate pathways: the activation
of PLC coupled to a PTX-insensitive G protein and the acti-
vation of a pertussis toxin (PTX)-sensitive G protein leading
to activation of p21ras, MAPK and accumulation of cAMP
(van Corven et al., 1993). To elucidate which of the pathways
is connected to the cytoskeletal changes observed upon LPA
stimulation, we studied the effects of PTX (Fig. 10) and a PLC
inhibitor, the aminosteroid U-73122 (Bleasdale et al., 1990;
Smith et al., 1990) (Fig. 11) during the stimulation of quiescent
cells with LPA. We found that up to 500 ng/ml PTX had no
effect on stimulated cells (Fig. 10E,F). In contrast, U-73122, a
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Fig. 5. Tyrosine kinase inhibitors, erbstatin analog and genistein, block the cytoskeletal response to serum. Serum-starved 3T3 cells (A,B,C)
were stimulated for 30 minutes either with 0.5% FBS alone (D,E,F) or serum to which either 10 µg/ml erbstatin analog (G,H,I) or 50 µg/ml
genistein (J,K,L) were added. Erbstatin analog was present in the incubation media during the last 1 hour of starvation and during stimulation.
Genistein was in the incubation media for the last 3 hours of starvation and during stimulation. Cells were stained for vinculin (A,D,G,J), actin
(B,E,H,K) or phosphotyrosine (C,F,I,L). Bar, 20 µM.
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PLC inhibitor, blocked the reformation of stress fibers and
focal adhesions in response to treatment with LPA (Fig.
11E,F). In addition, cell morphology was affected, the cells
appeared to be retracted, indicating decreased adhesion and/or
increased contractility. The inactive analog of the inhibitor, U-
73343, had no effect on the response to LPA (Fig. 11G,H).
These results indicate that activation of PLC is involved in the
cytoskeletal rearrangements induced by LPA. Previous work
has demonstrated the tyrosine phosphorylation of proteins
including FAK following PLC activation (Hordijk et al., 1994).
Together these data argue that cytoskeletal regulation by LPA
occurs via the PLC signaling pathway rather than the PTX-
sensitive G-protein pathway. 
DISCUSSION
Cell adhesion to ECM is associated with the tyrosine phos-
phorylation of a small set of proteins (Guan et al., 1991;
Burridge et al., 1992b; Kornberg et al., 1992; Romer et al.,
1992; Bockholt and Burridge, 1993). This tyrosine phospho-
rylation has been implicated in the assembly of focal adhesions
and stress fibers as cells spread on an ECM substratum. Not
only is the focal adhesion kinase, FAK, one of the proteins that
becomes phosphorylated in response to adhesion (Burridge et
al., 1992b; Guan and Shalloway, 1992; Hanks et al., 1992;
Kornberg et al., 1992; Pelletier, 1992; Romer et al., 1992), but
its activity is also stimulated (Guan and Shalloway, 1992;
Lipfert et al., 1992; Romer et al., 1994). In addition, inhibition
Fig. 7. Lysophosphatidic acid stimulates reorganization of the actin cytoskeleton. Quiescent, starved 3T3 cells (A,B,C) were stimulated for 30
minutes either with 0.5% FBS (D,E,F) or 200 ng/ml LPA (G,H,I). Cells were stained for vinculin (A,D,G), actin (B,E,H) or phosphotyrosine
(C,F,I). Bar, 20 µm.






serum-starved cells (lane 1),
that were then stimulated
with either 0.5% FBS alone
(lane 2), or with the addition
of tyrosine kinase inhibitors.
Erbstatin analog was added
at 15 µg/ml (lane 3) or 50
µg/ml (lane 4); genistein was
used at 100 µg/ml (lane 5) or
250 µg/ml (lane 6). Erbstatin
analog was present in the
incubation media during the
last 1 hour of starvation and
during serum-stimulation.
Genistein was added 3 hours
prior to and during
stimulation. The blot was
probed with anti-phosphotyrosine and then stripped and reprobed
with anti-FAK to ensure equal protein loading (data not shown).
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of FAK by herbimycin A and tyrphostins prevents the
formation of focal adhesions (Burridge et al., 1992; Romer et
al., 1992, 1994).
Here we have used another model system for studying the
formation of stress fibers and focal adhesions in starved and
quiescent fibroblasts (Rozengurt and Sinnett-Smith, 1983;
Ridley and Hall, 1992). Rho A can be activated by serum,
LPA, and to a lesser extent some growth factors, resulting in
the rapid assembly of focal adhesions and stress fibers (Ridley
and Hall, 1992). In this paper we demonstrate that FAK
becomes tyrosine phosphorylated as the formation of new
stress fibers and focal adhesions is induced by serum or LPA
treatment.
In order to establish whether tyrosine phosphorylation is the
cause or the result of the formation of the new cytoskeletal
structures, we have attempted either to promote intracellular
tyrosine phosphorylation by using tyrosine phosphatase
inhibitors, or to decrease the level of tyrosine phosphorylation
by using tyrosine kinase inhibitors. We have found that per-
vanadate treatment of starved, quiescent Swiss 3T3 cells
rapidly induces the formation of focal adhesions and stress
fibers. A concomitant increase in the tyrosine phosphorylation
of FAK has also been observed. Pervanadate is a broad
spectrum tyrosine phosphatase inhibitor and elevated the level
of phosphotyrosine in many proteins (data not shown). It is of
interest that previous work has shown that pervanadate stimu-
lates the formation of focal adhesions in MDCK cells, while at
the same time promoting the disassembly of the cell-cell
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Fig. 8. Tyrphostin 47 inhibits LPA-
induced actin reorganization.
Tyrphostin 47 at 120 µM was present in
the incubation media during 24 hours of
starvation (A,B) and during a 30 minute
stimulation with either 0.5% FBS (C,D)
or 200 ng/ml LPA (E,F). Cells were
stained for vinculin (A,C,E) or actin
(B,D,F). Bar, 20 µm.
Fig. 9. Tyrphostins inhibit LPA-induced FAK phosphorylation. FAK
was immunoprecipitated from starved cells (lane 1), cells stimulated
with either 0.5% FBS for 5 minutes (lane 2) or 200 ng/ml LPA (5
minutes, lane 3 and 30 minutes, lane 4). Tyrphostin 47 at 120 µM
was present during serum-starvation (lane 5) and following 30-
minute stimulation with 0.5% FBS (lane 6) or 200 ng/ml LPA (lane
7). In lane 8, the conditions were as in lane 7, but tyrphostin 25 was
used instead of tyrphostin 47. The blot was probed with anti-
phosphotyrosine.
3651FAK phosphorylation and focal adhesions
junctions in these cells (Volberg et al., 1992). Phenylarsine
oxide is a protein tyrosine phosphatase inhibitor with a
narrower specificity than pervanadate, inhibiting primarily
membrane-associated protein tyrosine phosphatases (Garcia-
Morales et al., 1990; Liao et al., 1991). In quiescent 3T3 cells,
phenylarsine oxide did not stimulate tyrosine phosphorylation
of FAK, nor did it promote the assembly of stress fibers and
focal adhesions.
Two tyrosine kinase inhibitors (genistein and EA), had the
opposite effect of pervanadate. These inhibitors blocked both
the tyrosine phosphorylation of FAK and the reappearance of
stress fibers and focal adhesions in response to serum stimula-
tion. These results support the idea that FAK tyrosine phos-
phorylation and, by implication, FAK activity have a role in
the assembly of focal adhesions and stress fibers. However,
these inhibitors suffer the disadvantage of having broad speci-
ficities. Genistein is a competitive inhibitor of the ATP binding
site, which is a conserved structural feature in all protein
kinases. It also non-competitively inhibits phosphor acceptor
substrate binding to protein kinases. Accordingly, genistein has
been shown to inhibit some serine/threonine kinases (Akiyama
et al., 1987; Linassier et al., 1989). Erbstatin and its analog
(EA) structurally mimic the tyrosyl moiety and thus show more
specificity towards tyrosine kinases. The erbstatin analog we
used (Umezawa et al., 1989) retains the inhibitory activity of
erbstatin and has an advantage over erbstatin by being more
stable in serum and having reduced polarity, which facilitates
membrane penetration. Both of these inhibitors non-competi-
tively inhibit ATP binding (Umezawa et al., 1986; Imoto et al.,
1987; Isshiki et al., 1987), and hence at higher concentrations
can inhibit serine/threonine kinases (Bishop et al., 1990; Salari
et al., 1990). For these reasons we turned to explore the effects
of various tyrphostins.
Tyrphostins are a family of inhibitors designed to bind com-
petitively to the phosphor acceptor site in the kinase domain
of tyrosine kinases (Yaish et al., 1988; Gazit et al., 1989).
These are tyrosine kinase specific and do not inhibit PKA, PKC
or other serine/threonine kinases (Levitzki, 1990). Tyrphostins
have ben used to inhibit FAK phosphorylation in response to
cell adhesion and migration (tyrphostin 47) (Romer et al.,
1994), as well as bombesin stimulation (tyrphostin 25) (Seckl
and Rozengurt, 1993). However, in the current work, neither
tyrphostin was found to completely prevent FAK phosphory-
lation or the induction of focal adhesions and stress fibers in
response to serum stimulation of quiescent cells. This finding
was surprising, since tyrphostins have been effective at inhibit-
ing FAK previously (Romer et al., 1994; Seckl and Rozengurt,
1993), and inhibited FAK phosphorylation in this study when
LPA was used as a stimulus. One possible explanation is that
serum stimulates the reappearance of stress fibers and focal
adhesions by an additional pathway, distinct from LPA and
FAK activation. An unidentified kinase in this pathway could
be responsible for phosphorylating FAK. The activity of this
kinase would be inhibited by erbstatin and genistein, broad
Fig. 10. PTX does not affect LPA-
induced actin reorganization.
Quiescent, starved 3T3 cells (A,B)
were stimulated for 30 minutes
either with 200 ng/ml LPA alone
(C,D) or LPA with 500 ng/ml PTX
(E,F). Cells were stained for
vinculin (A,C,E) or actin (B,D,F).
Bar, 20 µm.
3652
spectrum kinase inhibitors, but not by the tyrphostins used in
this study. These tyrphostins could prevent the autophospho-
rylation of FAK, but not its phosphorylation by this other
kinase. Future work will be needed to determine whether
another kinase is involved in the cytoskeletal response to
serum.
At present, the signaling pathway leading from LPA to the
formation of stress fibers and focal adhesions, is not well
understood. LPA is known to act via a membrane receptor,
coupled to two distinct G protein-linked pathways (Hordijk et
al., 1994). One, starting at a pertussis toxin-sensitive het-
erotrimeric Gi protein, leads through an unidentified kinase to
the activation of p21ras (van Corven et al., 1993) and MAP
kinase (Hordijk et al., 1994). Independent of this mitogenic
pathway, another G protein (pertussis toxin-insensitive)
couples the LPA receptor to PLC activation (van Corven et al.,
1989; Plevin et al., 1991). The PLC pathway was also
suggested to lead to the phosphorylation of several proteins,
including FAK (Hordijk et al., 1994, see also review by
Moolenaar, 1994). Consistent with this theory, we found that
an inhibitor of PLC, but not pertussis toxin, blocked the
response of cells to LPA.
LPA also leads to the activation of RhoA (Ridley and Hall,
1992) and this is required for the formation of focal adhesions
and stress fibers. The mechanism of RhoA activation by LPA
is not known. However, it has been shown that inhibition of
RhoA by Clostridium botulinum C3 exotransferase inhibits
LPA-induced FAK phosphorylation (Kumagai et al., 1993).
This suggests that RhoA acts upstream of FAK. It will be
important to determine how RhoA activates FAK, whether this
is the result of a direct interaction or whether there are multiple
steps between these two regulatory proteins.
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Fig. 11. PLC is involved in LPA-
induced actin reorganization.
Quiescent, starved 3T3 cells (A,B)
were stimulated for 30 minutes
either with 200 ng/ml LPA alone
(C,D) or LPA with PLC inhibitor,
U-73122 (E,F) or LPA with an
inactive form of the inhibitor, U-
73343 (G,H). Vinculin (A,C,E,G)
and actin (B,D,F,H) are visualized.
Bar, 20 µm.
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Note added in proof
While this manuscript was in preparation, two similar studies
by Ridley and Hall (EMBO J. 13, 2600-2610, 1994) and Barry
and Critchley (J. Cell Sci. 107, 2033-2045, 1994) were
published. These papers reached essentially the same conclu-
sion that a tyrosine kinase is involved in rho-induced formation
of stress fibers. This effect of rho can be blocked by a tyrosine
kinase inhibitor, genistein, and mimicked by a tyrosine phos-
phatase inhibitor, vanadyl hydroperoxide. In addition, activa-
tion of rhoA was shown to correlate with elevated levels of
FAK tyrosine phosphorylation which, in turn, was associated
with the formation of focal adhesions and stress fibers.
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